Skunkworks for healthcare wants to use AI to design new drugs

Jan. 4, 2018

Insilico Medicine, a Baltimore-based artificial intelligence company specializing in drug discovery, is hoping to mine the brains of medicinal chemists, the people who come up with drugs.

If successful, that could mean Insilico will be able to generate ideas for new, better drugs much faster than can be done presently.

The crowdsourced project, which Insilico is calling Chemistry.AI, hinges on monitoring and collecting data from highly-trained medicinal chemists as they work, allowing the company’s AI to glean insights into complex decision-making processes.

To capture the decision-making process, participating scientists will wear an electroencephalography (EEG) headset made by a company called Emotiv. The Emotiv headset also tracks head movement and facial expressions while cameras track the chemists’ eye movement.

On a computer screen, the chemists will see various molecules, some of which are generated by Insilico’s AI, some of which are drawn by humans, and some of which have already failed or succeeded in clinical trials.

“Medicinal chemists with several years of experience have the ability to distinguish the good molecules from the bad ones just by looking at their structure or its numerical properties and various scores,” explains Insilico founder Dr. Alex Zhavoronkov.

As the scientists look at molecules on a computer screen, the headset will essentially record the process by which they form assumptions, such as whether the molecules will lead to toxicity in humans. Over time, the aggregated data could teach Insilico’s deep learning AI to produce effective, safe molecules.

Aside from increasing the speed with which new drugs can be formulated, an AI-led process would also reduce inherent blindspots that even the best-trained medicinal chemists have.

By collecting data from enough high-performing chemists, Insilico hopes to create AI applications that can discover new drugs while counteracting those individual biases.

ZDNet has the full article

Sponsored Recommendations

Enhancing Remote Radiology: How Zero Trust Access Revolutionizes Healthcare Connectivity

This content details how a cloud-enabled zero trust architecture ensures high performance, compliance, and scalability, overcoming the limitations of traditional VPN solutions...

Spotlight on Artificial Intelligence

Unlock the potential of AI in our latest series. Discover how AI is revolutionizing clinical decision support, improving workflow efficiency, and transforming medical documentation...

Beyond the VPN: Zero Trust Access for a Healthcare Hybrid Work Environment

This whitepaper explores how a cloud-enabled zero trust architecture ensures secure, least privileged access to applications, meeting regulatory requirements and enhancing user...

Enhancing Remote Radiology: How Zero Trust Access Revolutionizes Healthcare Connectivity

This content details how a cloud-enabled zero trust architecture ensures high performance, compliance, and scalability, overcoming the limitations of traditional VPN solutions...